Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.35 |
| ▸ | CA6 | P23280 | 4/20 | 0.35 |
| ▸ | CA7 | P43166 | 4/20 | 0.35 |
| ▸ | CA9 | Q16790 | 4/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.35 |
| ▸ | RECQL | P46063 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA4 | P22748 | 3/20 | 0.33 |
| ▸ | CA5A | P35218 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CA3 | P07451 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5932373 | 0.93 | — | — | |
| SCHEMBL9349287 | 0.91 | CA12 (0.48) | CA12CA6CA7CA9CA14 | |
| SCHEMBL13768916 | 0.90 | HTR1D (0.32) | MEN1KMT2AHTR1DHTR1B | |
| Hydrochloric Acid SCHEMBL14311915 | 0.90 | HTR1D (0.32) | HTR1DHTR1B | |
| SCHEMBL8227905 | 0.90 | HTR1D (0.32) | MEN1KMT2AHTR1DHTR1B | |
| SCHEMBL21765336 | 0.90 | HTR1D (0.32) | MEN1KMT2AHTR1DHTR1B | |
| SCHEMBL12256715 | 0.90 | HTR1D (0.32) | MEN1KMT2AHTR1DHTR1B | |
| SCHEMBL19733594 | 0.90 | HTR1D (0.32) | MEN1KMT2AHTR1DHTR1B | |
| SCHEMBL22448482 | 0.90 | HTR1D (0.32) | MEN1KMT2AHTR1DHTR1B | |
| Hydrochloric Acid SCHEMBL15808481 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2438038-B1 | PROCESS FOR THE PREPARATION OF SECONDARY OR TERTIARY AMINES | HUNTSMAN CORP HUNGARY ZRT (HU) | 2016-04-20 | — | — | EP | disclosed |
| EP-2438039-B1 | A METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | HUNTSMAN CORP HUNGARY ZRT (HU) | 2013-07-31 | — | — | EP | disclosed |
| US-20120130132-A1 | METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | HUNTSMAN INTERNATIONAL LLC | 2012-05-24 | — | — | US | disclosed |
| WO-2010139521-A1 | A METHOD FOR PROVIDING A SECONDARY OR TERTIARY AMINE | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2010-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120130132-A1 | METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | NCLN, NCL, DNPH1 | CA12 2473/4885CA6 3192/4885CA7 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.